EZH2 and glioblastoma: Our results demonstrated a massive impairment of viability and invasion of 2D- and 3D-GBM cultures upon dual EZH2 and CDK4/6 blockade with the two blood-brain barrier penetrating agents GSK126 and abemaciclib10,26.